GDC-2992 (Compound 28A) is an orally bioavailable androgen receptor (AR) PROTAC degrader. GDC-2992 degrads AR with a DC50 value of 2.7 nM and inhibits proliferation with an IC50 valude of 9.7 nM in VCaPcells. GDC-2992 can be used for prostatic cancer study. (Structure Note: Pink: target protein ligand (HY-130845), Blue: E3 ligase ligand (HY-W1003189A), Black: linker (HY-169975), E3 ligase ligand +linker (HY-169976A))[1].
Molekulargewicht:
819.39
Reinheit:
99.38
CAS Nummer:
[2753651-10-2]
Formel:
C45H51ClN8O5
Target-Kategorie:
Androgen Receptor,PROTACs
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten